deltatrials
Completed PHASE3 NCT00002496

Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Cancer of the Larynx

PHASE III TRIAL TO PRESERVE THE LARYNX: INDUCTION CHEMOTHERAPY AND RADIATION THERAPY VERSUS CONCOMITANT CHEMOTHERAPY AND RADIATION THERAPY VERSUS RADIATION THERAPY

Sponsor: Eastern Cooperative Oncology Group

Updated 7 times since 2017 Last updated: Jan 23, 2014 Started: Aug 31, 1992 Primary completion: Aug 31, 2002 Completion: Nov 30, 2013

This PHASE3 trial investigates Head and Neck Cancer and is currently completed. Eastern Cooperative Oncology Group leads this study, which shows 7 recorded versions since 1992 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Change History

7 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. May 2023 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jan 2021 — May 2023 [monthly]

    Completed PHASE3

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

Show 2 earlier versions
  1. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE3

  2. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE3

    First recorded

Aug 1992

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Eastern Cooperative Oncology Group
  • National Cancer Institute (NCI)
  • Radiation Therapy Oncology Group
  • SWOG Cancer Research Network
Data source: Radiation Therapy Oncology Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Boston, United States, Cleveland, United States, Decatur, United States, Denver, United States, Des Moines, United States, East Orange, United States, Hackensack, United States, Indianapolis, United States, Kalamazoo, United States, Peoria, United States and 6 more location s